Cargando…
Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs
AIM: To quantify the economic burden of early-stage non-small-cell lung cancer (NSCLC) among patients with and without adjuvant therapy. METHODS: All-cause and NSCLC-related healthcare resource utilization and medical costs were assessed among patients with resected stage IB–IIIA NSCLC in the SEER–M...
Autores principales: | Apple, Jon, DerSarkissian, Maral, Shah, Anne, Chang, Rose, Chen, Yan, He, Xuanhao, Chun, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Becaris Publishing Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690396/ https://www.ncbi.nlm.nih.gov/pubmed/37655686 http://dx.doi.org/10.57264/cer-2023-0107 |
Ejemplares similares
-
Prolonged oral corticosteroid treatment in patients with systemic lupus erythematosus: An evaluation of 12-month economic and clinical burden
por: Huang, Shirley P, et al.
Publicado: (2023) -
Clinical and Economic Burden in Patients With Systemic Lupus Erythematosus During the First Year After Initiating Oral Corticosteroids: A Retrospective US Database Study
por: DerSarkissian, Maral, et al.
Publicado: (2023) -
Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States
por: DerSarkissian, Maral, et al.
Publicado: (2016) -
Removal of ineligible outcome cases reduces confounding
por: Walker, Alexander M, et al.
Publicado: (2018) -
Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer
por: Bobbili, Priyanka, et al.
Publicado: (2020)